CID 509909

Schembl7477523

Structural Information

Molecular Formula
C28H35N5OS
SMILES
CC(C)C1=CC(=C(C(=C1)C(C)C)C(=O)NC2=NN=C(S2)NCCC3=CNC4=CC=CC=C43)C(C)C
InChI
InChI=1S/C28H35N5OS/c1-16(2)20-13-22(17(3)4)25(23(14-20)18(5)6)26(34)31-28-33-32-27(35-28)29-12-11-19-15-30-24-10-8-7-9-21(19)24/h7-10,13-18,30H,11-12H2,1-6H3,(H,29,32)(H,31,33,34)
InChIKey
YWIYAYZFCDIKOL-UHFFFAOYSA-N
Compound name
N-[5-[2-(1H-indol-3-yl)ethylamino]-1,3,4-thiadiazol-2-yl]-2,4,6-tri(propan-2-yl)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

4
Patents

489.25623 Da
Monoisotopic Mass

7.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 490.26351 221.1
[M+Na]+ 512.24545 226.3
[M-H]- 488.24895 227.9
[M+NH4]+ 507.29005 228.7
[M+K]+ 528.21939 219.6
[M+H-H2O]+ 472.25349 212.2
[M+HCOO]- 534.25443 233.1
[M+CH3COO]- 548.27008 227.7
[M+Na-2H]- 510.23090 214.8
[M]+ 489.25568 225.8
[M]- 489.25678 225.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe